SARAH MACKEY: Open Payments
NPI 1275102113 · DECATUR, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,547 in 117 payments from 33 companies in 2025. Trend: 2023 $0 · 2024 $1,847 · 2025 $2,547
Food & beverage: $2,369Education: $178
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $366 |
| AstraZeneca Pharmaceuticals LP | 17 | $334 |
| Novartis Pharmaceuticals Corporation | 15 | $334 |
| Merck Sharp & Dohme LLC | 12 | $203 |
| Janssen Biotech, Inc. | 7 | $180 |
| Daiichi Sankyo Inc. | 7 | $145 |
| Genentech USA, Inc. | 5 | $107 |
| Gilead Sciences, Inc. | 1 | $85 |
| PFIZER INC. | 4 | $79 |
| Astellas Pharma US Inc | 3 | $68 |
Products named: EPKINLY, KEYTRUDA, IMFINZI, VENCLEXTA, Fabhalta, ENHERTU, DARZALEX, KISQALI.
Industry payments across IL — which companies pay providers there.
